三辨相和在肝癌治疗中的应用
|
摘要
原发性肝癌(以下简称"肝癌")在我国有较高的发病率及死亡率,是临床难治疾病之一。西医对肝癌的治疗方法虽然多种多样,但基于肝癌的病理特性,未能取得令人满意的治疗效果。在中医治疗方面,单一的辨证论治在肝癌的治疗上存在诸多不足,但其在长期的临床实践中确立了辨病-辨病机-辨证的临床思维模式来探究肝癌的中医治疗,确立了肝癌的基本病机及治则,并例举临床验案1则,以期为肝癌的治疗提供更多的临床诊疗思路,为广大肝癌患者带来福音。
Primary hepatocellular carcinoma( "liver cancer" for short) has a high incidence and mortality in China, and is one of the clinical refractory diseases. Although the treatment methods of Western medicine for liver cancer are various, it has not achieved satisfactory results based on the pathological characteristics of liver cancer. In the aspect of traditional Chinese medicine treatment, there are many deficiencies in the treatment of liver cancer with single syndrome differentiation, but in the long-term clinical practice, it has established the clinical thinking mode of disease differentiation-pathogenesis differentiation-syndrome differentiation to explore the traditional Chinese medicine treatment of liver cancer, established the basic pathogenesis and treatment principles of liver cancer, and cited one clinical case to provide more clinical diagnosis and treatment ideas for the treatment of liver cancer, and for the general liver cancer brings good news.
Primary hepatocellular carcinoma( "liver cancer" for short) has a high incidence and mortality in China, and is one of the clinical refractory diseases. Although the treatment methods of Western medicine for liver cancer are various, it has not achieved satisfactory results based on the pathological characteristics of liver cancer. In the aspect of traditional Chinese medicine treatment, there are many deficiencies in the treatment of liver cancer with single syndrome differentiation, but in the long-term clinical practice, it has established the clinical thinking mode of disease differentiation-pathogenesis differentiation-syndrome differentiation to explore the traditional Chinese medicine treatment of liver cancer, established the basic pathogenesis and treatment principles of liver cancer, and cited one clinical case to provide more clinical diagnosis and treatment ideas for the treatment of liver cancer, and for the general liver cancer brings good news.
引文
[1]Lafaro KJ,Demirjian AN,Pawlik TM.Epidemiology of hepatocellular carcinoma[J].Surgical Oncology Clinics of North America,2015,24(1):1-17.
[2]Forner A,Llovet JM,Bruix J.Hepatocellular carcinoma[J].Lancet,2012,379(9822):1245-1255.
[3]郝捷,陈万青.中国肿瘤登记年报(2012)[M].北京:军事医学科学出版社,2012:27-60.
[4]Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].Can J Clin,2016,66(2):115-132.
[5]Torre LA,Bray F,Siegel RL,et al.Global cancer statistics,2012[J].CA Cancer J Clin 2015,65:87-108.
[6]European Association for the Study of the Liver,European Organisation for Research and Treatment of Cancer.EASLE-ORTC clinical pactice guide Lines:management of hepato cellular carcinoma[J].J Hepatol,2012,56(4):908-943.
[7]李江艳.扶正消瘤法治疗恶性肿瘤虚证78例[J].中国中医药现代远程教育,2013,11(19):29-30.
[8]胡文雷,徐焕海.扶正补虚方对原发性肝癌患者细胞免疫功能及生活质量的影响[J].中国中西医结合消化杂志,2014,22(8):444-446,450.
[9]何若苹,徐光星,顾锡冬.何任教授中医药辨治肝癌经验探讨[J].中西医结合肝病杂志,2012,22(3):174-175.
[10]周宇姝,龙顺钦.吴万垠教授辨治原发性肝癌经验浅析[J].亚太传统医药,2012,8(7):47-48.
[11]叶丽红,程海波,吴勉华,等.原发性肝癌中医病机特点思考[J].中医杂志,2010,51(6):557-559.
[12]陈赐慧,花宝金.花宝金教授调畅情志治疗肿瘤经验[J].吉林中医药,2012,32(6):566-567.
[13]邓铁涛.辨证论治是中医学的精髓[J].中医药通报,2005,4(1):1-4.
[14]何若苹,徐光星,顾锡东.何任教授中医药辨治肝癌经验探讨[J].中西医结合肝病杂志,2012,2(3):174-175.
[15]王爽,徐振晔,徐振晔治疗肝癌经验[J].北京中医药,2012,31(4):282-283.
[16]何立丽,孙桂芝.孙桂芝治疗原发性肝癌经验[J].上海中医药杂志,2009,43(8):3-4.
[17]李永健,方肇勤,唐辰龙,等.2060例原发性肝癌中医证候分布规律的临床流行病学调查研究[J].中国医药学报,2003,18(3):144-146.
[18]侯风刚,凌昌全,赵钢,等.原发性肝癌中医基本证候临床分布状况调查分析[J].上海中医药杂志,2005,39(2):22-23.
[19]张院辉,覃晓,徐静,等.原发性肝癌患者手术前后中医证候特点研究[J].江苏中医药,2010,2(12):13-14.
[20]斯韬,宁雪坚,冯献斌,等.312例原发性肝癌患者血管介入栓塞化疗前后中医证候研究[J].中医杂志,2015,56(19):1678-1681.
[21]袁菊花,吴煜.健脾化痰法在肝癌治疗中的相关理论及应用[J].辽宁中医药大学学报,2012,14(6):85-87.
[2]Forner A,Llovet JM,Bruix J.Hepatocellular carcinoma[J].Lancet,2012,379(9822):1245-1255.
[3]郝捷,陈万青.中国肿瘤登记年报(2012)[M].北京:军事医学科学出版社,2012:27-60.
[4]Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].Can J Clin,2016,66(2):115-132.
[5]Torre LA,Bray F,Siegel RL,et al.Global cancer statistics,2012[J].CA Cancer J Clin 2015,65:87-108.
[6]European Association for the Study of the Liver,European Organisation for Research and Treatment of Cancer.EASLE-ORTC clinical pactice guide Lines:management of hepato cellular carcinoma[J].J Hepatol,2012,56(4):908-943.
[7]李江艳.扶正消瘤法治疗恶性肿瘤虚证78例[J].中国中医药现代远程教育,2013,11(19):29-30.
[8]胡文雷,徐焕海.扶正补虚方对原发性肝癌患者细胞免疫功能及生活质量的影响[J].中国中西医结合消化杂志,2014,22(8):444-446,450.
[9]何若苹,徐光星,顾锡冬.何任教授中医药辨治肝癌经验探讨[J].中西医结合肝病杂志,2012,22(3):174-175.
[10]周宇姝,龙顺钦.吴万垠教授辨治原发性肝癌经验浅析[J].亚太传统医药,2012,8(7):47-48.
[11]叶丽红,程海波,吴勉华,等.原发性肝癌中医病机特点思考[J].中医杂志,2010,51(6):557-559.
[12]陈赐慧,花宝金.花宝金教授调畅情志治疗肿瘤经验[J].吉林中医药,2012,32(6):566-567.
[13]邓铁涛.辨证论治是中医学的精髓[J].中医药通报,2005,4(1):1-4.
[14]何若苹,徐光星,顾锡东.何任教授中医药辨治肝癌经验探讨[J].中西医结合肝病杂志,2012,2(3):174-175.
[15]王爽,徐振晔,徐振晔治疗肝癌经验[J].北京中医药,2012,31(4):282-283.
[16]何立丽,孙桂芝.孙桂芝治疗原发性肝癌经验[J].上海中医药杂志,2009,43(8):3-4.
[17]李永健,方肇勤,唐辰龙,等.2060例原发性肝癌中医证候分布规律的临床流行病学调查研究[J].中国医药学报,2003,18(3):144-146.
[18]侯风刚,凌昌全,赵钢,等.原发性肝癌中医基本证候临床分布状况调查分析[J].上海中医药杂志,2005,39(2):22-23.
[19]张院辉,覃晓,徐静,等.原发性肝癌患者手术前后中医证候特点研究[J].江苏中医药,2010,2(12):13-14.
[20]斯韬,宁雪坚,冯献斌,等.312例原发性肝癌患者血管介入栓塞化疗前后中医证候研究[J].中医杂志,2015,56(19):1678-1681.
[21]袁菊花,吴煜.健脾化痰法在肝癌治疗中的相关理论及应用[J].辽宁中医药大学学报,2012,14(6):85-87.